Patricia C. Galipeau

Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection (2007)

Xiaohong Li, Steven G. Self, Patricia C. Galipeau, Thomas G. Paulson, Brian J. Reid

Single nucleotide polymorphisms (SNPs) have been increasingly utilized to investigate somatic genetic abnormalities in premalignancy and cancer. LOH is a common alteration observed during cancer...

NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma (2007)

Patricia C. Galipeau, Xiaohong Li, Patricia L. Blount, Carlo C. Maley, Carissa A. Sanchez, Robert D. Odze, ...

BackgroundSomatic genetic CDKN2A, TP53, and DNA content abnormalities are common in many human cancers and their precursors, including esophageal adenocarcinoma (EA) and Barrett's esophagus (BE),...

Serum Selenium Levels in Relation to Markers of Neoplastic Progression Among Persons With BarrettÂ’s Esophagus (2003)

Rudolph, Rebecca E., Vaughan, Thomas L., Kristal, Alan R., Blount, Patricia L., Levine, Douglas S., Galipeau, Patricia C., ...

Background: Persons with Barrett’s esophagus have a substantially greater risk of esophageal adenocarcinoma than the general population. Higher serum selenium levels have been associated with a...

Clonal Expansion and Loss of Heterozygosity at Chromosomes 9p and 17p in Premalignant Esophageal (Barrett's) Tissue (1999)

Galipeau, Patricia C., Prevo, Laura J., Sanchez, Carissa A., Longton, Gary M., Reid, Brian J.

BACKGROUND: Abnormalities involving the p16 (also known as cyclin-dependent kinase N2 [CDKN2], p16 [INK4a], or MTS1) and p53 (also known as TP53) tumor suppressor genes are highly...

Loss of Heterozygosity Analysis Using Whole Genome Amplification, Cell Sorting, and Fluorescence-Based PCR

Paulson, Thomas G., Galipeau, Patricia C., Reid, Brian J.

Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending investigation of LOH to large-scale clinical and public health science studies has proven difficult...

Loss of Heterozygosity Analysis Using Whole Genome Amplification, Cell Sorting, and Fluorescence-Based PCR

Paulson, Thomas G., Galipeau, Patricia C., Reid, Brian J.

Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending investigation of LOH to large-scale clinical and public health science studies has proven difficult...

NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma

Galipeau, Patricia C, Li, Xiaohong, Blount, Patricia L, Maley, Carlo C, Sanchez, Carissa A, Odze, Robert D, ...

In a ten-year study of people with Barrett's esophagus, nonsteroidal anti-inflamatory drugs were associated with reduced risk of esophageal adenocarcinoma, especially in patients with multiple...

Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection

Li, Xiaohong, Self, Steven G, Galipeau, Patricia C, Paulson, Thomas G, Reid, Brian J

Single nucleotide polymorphisms (SNPs) have been increasingly utilized to investigate somatic genetic abnormalities in premalignancy and cancer. LOH is a common alteration observed during cancer...